US Patent Issued to Jiangnan University on July 21 for "Application of stachyose in preparation of drug for treating castration-resistant prostate cancer" (Chinese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,742, issued on July 21, was assigned to Jiangnan University (Wuxi, China).

"Application of stachyose in preparation of drug for treating castration-resistant prostate cancer" was invented by Rong Wang (Wuxi, China), Yongquan Chen (Wuxi, China), Lu Xu (Wuxi, China), Xiaoying Wang (Wuxi, China) and Shenglong Zhu (Wuxi, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is an application of Stachyose in preparation of a drug for treating castration-resistant prostate cancer, belonging to the technical field of biological medicine. The disclosure proposes a new strategy of using Stachyose in combination with an androgen receptor antagonist t...